0
0.5
1
1.5
2+
Mortality
55%
Improvement
Relative Risk
ICU admission
29%
Hospitalization
37%
HCQ for COVID-19 Ip et al. EARLY TREATMENT
Is early treatment with HCQ beneficial for COVID-19?
Retrospective 1,067 patients in the USA
Lower hospitalization with HCQ (p=0.038)
c19hcq.org
Ip et al., BMC Infectious Diseases, Aug 2020
Favors HCQ
Favors control